BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24613421)

  • 1. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro.
    Fenollar F; Perreal C; Raoult D
    Int J Antimicrob Agents; 2014 Apr; 43(4):388-90. PubMed ID: 24613421
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei.
    Fenollar F; Rolain JM; Alric L; Papo T; Chauveheid MP; van de Beek D; Raoult D
    Int J Antimicrob Agents; 2009 Sep; 34(3):255-9. PubMed ID: 19346107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
    Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
    J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropheryma whipplei endocarditis relapses after treatment with trimethoprim/sulfamethoxazole.
    Fenollar F; Lagier JC; Rolain JM; Célard M; Bouchot O; Eicher JC; Lepidi H; Raoult D
    Int J Antimicrob Agents; 2013 Jun; 41(6):592-4. PubMed ID: 23507410
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
    Lagier JC; Fenollar F; Lepidi H; Giorgi R; Million M; Raoult D
    J Antimicrob Chemother; 2014 Jan; 69(1):219-27. PubMed ID: 23946319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
    Lagier JC; Fenollar F; Lepidi H; Raoult D
    J Antimicrob Chemother; 2011 May; 66(5):1188-9. PubMed ID: 21393129
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of pentamidine against Tropheryma whipplei.
    Rolain JM; Fenollar F; Raoult D
    Int J Antimicrob Agents; 2011 Dec; 38(6):545-7. PubMed ID: 22005072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.
    Feurle GE; Moos V; Bläker H; Loddenkemper C; Moter A; Stroux A; Marth T; Schneider T
    J Infect; 2013 Mar; 66(3):263-70. PubMed ID: 23291038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: therapy for Whipple's disease.
    Bakkali N; Fenollar F; Rolain JM; Raoult D
    J Antimicrob Chemother; 2008 Apr; 61(4):968-9; author reply 969-70. PubMed ID: 18252691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations].
    Thabaut A
    Therapie; 1983; 38(4):399-404. PubMed ID: 6606237
    [No Abstract]   [Full Text] [Related]  

  • 12. Infection: How should classic Whipple disease be managed?
    Fenollar F; Raoult D
    Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):246-8. PubMed ID: 20442732
    [No Abstract]   [Full Text] [Related]  

  • 13. Tropheryma whipplei Infection (Whipple Disease) in the USA.
    Hujoel IA; Johnson DH; Lebwohl B; Leffler D; Kupfer S; Wu TT; Murray JA; Rubio-Tapia A
    Dig Dis Sci; 2019 Jan; 64(1):213-223. PubMed ID: 29572616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline.
    Emonet S; Wuillemin T; Harbarth S; Wassilew N; Cikirikcioglu M; Schrenzel J; Lagier JC; Raoult D; van Delden C
    Int J Infect Dis; 2015 Jan; 30():17-9. PubMed ID: 25461667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Whipple's disease: therapeutic strategy and long-term follow-up.
    Touitou V; Fenollar F; Cassoux N; Merle-Beral H; LeHoang P; Amoura Z; Drancourt M; Bodaghi B
    Ophthalmology; 2012 Jul; 119(7):1465-9. PubMed ID: 22420960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologically presenting Whipple disease: case report and review of the literature.
    Buckle MJ; Ellis RW; Bone M; Lockman H
    J Clin Pathol; 2008 Oct; 61(10):1140-1. PubMed ID: 18381382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whipple's in the valleys: a case of Whipple's with thrombocytopenia and endocarditis.
    Loughran D; Beale L; Lodge F; Habboush H; Stock D
    J Clin Pathol; 2014 May; 67(5):445-8. PubMed ID: 24459171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced endoscopic imaging using narrow-band imaging for diagnosis of Whipple's disease.
    Neumann H; Mönkemüller K; Neurath MF; Vieth M
    Endoscopy; 2012; 44 Suppl 2 UCTN():E101. PubMed ID: 22473576
    [No Abstract]   [Full Text] [Related]  

  • 19. Whipple's Disease.
    Neumann H; Mönkemüller K; Malfertheiner P
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):A32. PubMed ID: 18490201
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of Whipple's disease evolving over 30 years.
    Lochouarn M; Lagier JC; Raoult D; Pulcini C
    Med Mal Infect; 2014 Jul; 44(7):331-3. PubMed ID: 25015310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.